What types of derivatives can benefit from the pre-trade transparency waiver provided under Article 9(1)(c) of MiFIR?

An investment firm only offers financial instruments issued or provided by the investment firm itself or by entities having close links with the investment firm. On a look-through basis, the financial instruments offered (for example, investment funds, wrappers) allow the investor to indirectly invest in financial instruments issued by entities who do not have close links with the investment firm.

Can such investment firm hold itself out as providing investment advice on an independent basis?

In some instances, investment firms use the RFQ system of a trading venue that allow firms to identify and select the different counterparties they wish to obtain quotes from, before concluding the trade with the selected counterparty on that trading venue’s RFQ system.
Where an investment firm agrees a trade via such systems, should it identify the counterparty with whom the transaction was agreed with or the trading venue used to ultimately conclude the transaction for its RTS 28 reporting?

Where the NCA does not consent to the delay of disclosure under Article 17(5) of MAR, can a credit/financial institution or its parents undertaking resort to Article 17(4) of MAR?

Are credit/financial institutions or their parent undertakings required to notify the NCA of the expected duration of the delay under Article 17(5) of MAR?